Loading provider…
Loading provider…
Hematology & Oncology Physician in Indianapolis, IN
NPI: 1063477073Primary Practice Location
INDIANA UNIVERSITY HEALTH
1701 N Senate Blvd, Indianapolis, IN
Primary Employer
IU Health Medical Group, LLC
iuhealth.org
HQ Phone
Get MD Anne's Phone NumberMobile
Get MD Anne's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 174 | 228 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 95 | 183 |
| 3 | 99212Established patient outpatient visit, total time 10-19 minutes | 85 | 122 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 22 | 28 |
| 5 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 14 | 24 |
Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).
Authors: Amy Shapiro
Publication Date: 2011-02-18
Authors: Magdalena Lewandowska, Nicole Randall, Nihal Bakeer, Amy Shapiro
Journal: Haemophilia
Publication Date: 2020-11-27
Lead Sponsor: Lifespan
Collaborators: Doris Duke Charitable Foundation
Intervention / Treatment: DRUG: Hydroxyurea
Lead Sponsor: Indiana Hemophilia &Thrombosis Center, Inc.
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Emicizumab
Lead Sponsor: Indiana Hemophilia &Thrombosis Center, Inc.
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Emicizumab